Study shows potential of heartburn drug for COVID-19 According to an observational study, which was conducted at Irving, Medical Center of Columbia University (USA), could help a common drug for heartburn...

Little evidence supports the new recommendations for clinical screening for drug use. Do the potential benefits outweigh the potential harms? In the June 9 issue of JAMA, the U.S. Preventive Services...

Alcohol-related liver disease (ALD) is a deadly condition affecting more than 150 million people worldwide with no treatment available besides transplant. But now, a team led by researchers from Massachusetts...

The osteoporosis wonder drug that helps rebuild crumbling bones and could save 500,000 people a year a visit to the fracture clinic More than three million Britons suffer from the brittle bone disease...

A new study co-authored by a University of Central Florida researcher shows that laws that punish substance use during pregnancy actually do more harm than good. These unintended consequences include...

The U.S. Food and Drug Administration on Friday warned doctors against prescribing a malaria drug touted by President Donald Trump for treating the new coronavirus except in hospitals and research studies. In...

Capping decades of research, a new study may offer a breakthrough in treating dyskeratosis congenita and other so-called telomere diseases, in which cells age prematurely. Using cells donated by patients...

A collaborative study led by Monash University’s Biomedicine Discovery Institute (BDI) in Melbourne, Australia, with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), has...

In a study published this week in Science, Université de Montreal researchers report key structural and biochemical differences among a class of anti-cancer drugs known as PARP inhibitors. These distinguishing...

Researchers at the VU University Medical Center in the Netherlands have tested a new drug in patient samples and mice with multiple myeloma and discovered that it was effective even in advanced disease—a...